GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 723 filers reported holding GLAXOSMITHKLINE PLC in Q2 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $28,498,000 | +24.9% | 654,223 | +26.5% | 0.01% | +27.3% |
Q4 2021 | $22,813,000 | +87.7% | 517,291 | +62.7% | 0.01% | +57.1% |
Q3 2021 | $12,151,000 | +11.3% | 318,014 | +16.0% | 0.01% | +16.7% |
Q2 2021 | $10,913,000 | +25.4% | 274,060 | +12.4% | 0.01% | 0.0% |
Q1 2021 | $8,703,000 | -28.6% | 243,845 | -26.4% | 0.01% | -33.3% |
Q4 2020 | $12,189,000 | -65.9% | 331,212 | -65.1% | 0.01% | -71.9% |
Q3 2020 | $35,750,000 | -14.2% | 949,783 | -7.1% | 0.03% | -22.0% |
Q2 2020 | $41,687,000 | -6.8% | 1,022,003 | -13.4% | 0.04% | -22.6% |
Q1 2020 | $44,712,000 | -21.3% | 1,180,054 | -2.3% | 0.05% | -11.7% |
Q4 2019 | $56,785,000 | +19.3% | 1,208,441 | +8.3% | 0.06% | +15.4% |
Q3 2019 | $47,607,000 | +9.5% | 1,115,431 | +2.7% | 0.05% | -5.5% |
Q2 2019 | $43,470,000 | -0.6% | 1,086,206 | +3.8% | 0.06% | -8.3% |
Q1 2019 | $43,741,000 | +16.4% | 1,046,676 | +6.4% | 0.06% | +3.4% |
Q4 2018 | $37,577,000 | +5442.3% | 983,441 | +5729.2% | 0.06% | +5700.0% |
Q3 2018 | $678,000 | -91.7% | 16,871 | -91.7% | 0.00% | -94.7% |
Q2 2018 | $8,165,000 | +8.4% | 202,576 | +5.2% | 0.02% | -9.5% |
Q1 2018 | $7,530,000 | -40.7% | 192,555 | -46.2% | 0.02% | -25.0% |
Q4 2017 | $12,705,000 | -38.4% | 358,166 | -29.5% | 0.03% | -42.9% |
Q3 2017 | $20,635,000 | +0.6% | 508,370 | +6.9% | 0.05% | -14.0% |
Q2 2017 | $20,502,000 | +4.7% | 475,462 | +2.3% | 0.06% | -9.5% |
Q1 2017 | $19,591,000 | +14.7% | 464,719 | +4.7% | 0.06% | +1.6% |
Q4 2016 | $17,085,000 | -24.1% | 443,791 | -14.9% | 0.06% | -28.7% |
Q3 2016 | $22,496,000 | -9.7% | 521,584 | -9.3% | 0.09% | -12.1% |
Q2 2016 | $24,912,000 | +12.6% | 574,807 | +5.4% | 0.10% | +4.2% |
Q1 2016 | $22,124,000 | +4.9% | 545,603 | +4.3% | 0.10% | -1.0% |
Q4 2015 | $21,099,000 | +4.2% | 522,904 | -0.7% | 0.10% | -5.0% |
Q3 2015 | $20,253,000 | -6.7% | 526,746 | +1.0% | 0.10% | -1.9% |
Q2 2015 | $21,719,000 | -7.7% | 521,468 | +2.3% | 0.10% | -15.6% |
Q1 2015 | $23,526,000 | +2947.4% | 509,772 | +2723.3% | 0.12% | +1425.0% |
Q4 2014 | $772,000 | -14.0% | 18,056 | -7.6% | 0.01% | -11.1% |
Q3 2014 | $898,000 | +10.3% | 19,540 | +28.4% | 0.01% | +12.5% |
Q2 2014 | $814,000 | -10.5% | 15,220 | -10.6% | 0.01% | -20.0% |
Q1 2014 | $910,000 | +68.8% | 17,031 | +68.5% | 0.01% | +66.7% |
Q4 2013 | $539,000 | +7.8% | 10,105 | +1.3% | 0.01% | 0.0% |
Q3 2013 | $500,000 | +10.9% | 9,973 | +10.5% | 0.01% | 0.0% |
Q2 2013 | $451,000 | – | 9,028 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |